Scholarlink

Background <p>The increasing intake of sugar-sweetened (SSBs) and artificially sweetened beverages (ASBs) raises concerns over their potential impact on cardiovascular health. This umbrella meta-analysis examines their association with cardiovascular outcomes, synthesizing existing evidence comprehensively.</p> Methods <p>A systematic search was conducted across PubMed, Scopus, Web of Science, and Google Scholar databases, covering studies published up to November 2024. Eligible meta-analyses were synthesized using a random-effects model to calculate pooled effect sizes and 95% confidence intervals. Subgroup and sensitivity analyses were performed, and the methodological quality of studies was evaluated using AMSTAR 2 tools.</p> Results <p>Nineteen meta-analyses encompassing 67 datasets met the inclusion criteria. ASB consumption was associated with a 10% increased risk of mortality (RR: 1.10; 95% CI: 1.07 to 1.12), including an 8% increased risk of cardiovascular disease (CVD) mortality (RR: 1.08; 95% CI: 1.05 to 1.11). SSB intake was linked to a 9% higher overall mortality risk (RR: 1.09; 95% CI: 1.07 to 1.11) and a 10% increased CVD mortality risk (RR: 1.10; 95% CI: 1.07 to 1.13). Additional cardiovascular risks associated with both beverages included hypertension (RR range: 1.12–1.19), coronary heart disease (RR range: 1.09–1.20), metabolic syndrome (RR range: 1.19–1.31), and stroke (RR range: 1.06–1.25).</p> Conclusion <p>The results underscore a clear link between the intake of sweetened beverages and elevated risks of mortality and major cardiovascular outcomes, suggesting an urgent need to reduce their consumption as part of public health initiatives. Targeted strategies, including consumer education and policy interventions, may help mitigate these risks and improve cardiovascular health outcomes.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sweetened beverages and cardiovascular outcomes: an umbrella review of mortality and health outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月12日

查看全文
  • Mehrdad Jamali,
  • Paniz Anvarifard,
  • Banafshe Hosseini,
  • Maryam Razaghi,
  • Leila Khorraminezhad,
  • Ehsan Alvandi,
  • Mona Albadawy,
  • Meysam Zarezadeh,
  • Ahmad Saedisomeolia

摘要

Background

The increasing intake of sugar-sweetened (SSBs) and artificially sweetened beverages (ASBs) raises concerns over their potential impact on cardiovascular health. This umbrella meta-analysis examines their association with cardiovascular outcomes, synthesizing existing evidence comprehensively.

Methods

A systematic search was conducted across PubMed, Scopus, Web of Science, and Google Scholar databases, covering studies published up to November 2024. Eligible meta-analyses were synthesized using a random-effects model to calculate pooled effect sizes and 95% confidence intervals. Subgroup and sensitivity analyses were performed, and the methodological quality of studies was evaluated using AMSTAR 2 tools.

Results

Nineteen meta-analyses encompassing 67 datasets met the inclusion criteria. ASB consumption was associated with a 10% increased risk of mortality (RR: 1.10; 95% CI: 1.07 to 1.12), including an 8% increased risk of cardiovascular disease (CVD) mortality (RR: 1.08; 95% CI: 1.05 to 1.11). SSB intake was linked to a 9% higher overall mortality risk (RR: 1.09; 95% CI: 1.07 to 1.11) and a 10% increased CVD mortality risk (RR: 1.10; 95% CI: 1.07 to 1.13). Additional cardiovascular risks associated with both beverages included hypertension (RR range: 1.12–1.19), coronary heart disease (RR range: 1.09–1.20), metabolic syndrome (RR range: 1.19–1.31), and stroke (RR range: 1.06–1.25).

Conclusion

The results underscore a clear link between the intake of sweetened beverages and elevated risks of mortality and major cardiovascular outcomes, suggesting an urgent need to reduce their consumption as part of public health initiatives. Targeted strategies, including consumer education and policy interventions, may help mitigate these risks and improve cardiovascular health outcomes.

Graphical abstract